The human papillomaviruses (HPVs) are ubiquitous human pathogens that cause
a wide variety of benign and pre-malignant epithelial tumours. Of the almo
st 100 different types of HPV that have been characterized to date, approxi
mately two dozen specifically infect genital and oral mucosa. Mucosal HPVs
are most frequently sexually transmitted and, with an incidence roughly twi
ce that of herpes simplex virus infection, are considered one of the most c
ommon sexually transmitted diseases throughout the world. A subset of genit
al HPVs, termed 'high-risk' HPVs, is highly associated with the development
of genital cancers including cervical carcinoma. The absence of a simple m
onolayer cell culture system for analysis and propagation of the virus has
substantially retarded progress in the development of diagnostic and therap
eutic strategies for HPV infection. In spite of these difficulties, great p
rogress has been made in the elucidation of the molecular controls of virus
gene expression, replication and pathogenesis. With this knowledge and som
e important new tools, there is great potential for the development of impr
oved diagnostic and prognostic tests, prophylactic and therapeutic vaccines
, and traditional antiviral medicines.